Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1594852

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1594852

Global Vendor Neutral Archive (VNA) and PACS Market - 2024-2031

PUBLISHED:
PAGES: 212 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Overview

Global Vendor Neutral Archive (VNA) and PACS Market reached US$ 4.5 billion in 2023 and is expected to reach US$ 9.3 billion by 2031, growing with a CAGR of 9.50% during the forecast period 2024-2031.

Major drivers anticipated to drive the market under study include the growing demand for universal medical image archiving, the reduction of data storage prices and the high-level integration with the Electronic Health Records (EHR) industry. Furthermore, the widespread expectation for the digitalization of healthcare systems has heightened the need for medical archiving.

The July 2021 research article in the Diagnostics Journal highlighted the continuous generation of vast quantities of imaging data in daily clinical practice. This has resulted in the ongoing expansion of archives and the emergence of new ambitious initiatives globally to establish extensive medical imaging repositories. Hence, the research and studies indicate a strong need for medical imaging archives, which could potentially stimulate the expansion of the holistic market.

Research has recently been undertaken to elucidate the advantages and disadvantages of Picture Archiving and Communication Systems (PACS) and Virtual Network Assistants (VNAs). The findings indicate that organizations can effectively use PACS. However, in order to achieve long-term cost savings and efficient utilization of medical images, it is advisable to explore VNAs as a viable alternative for minimizing long-term expenses and enabling enhanced interoperability in handling crucial imaging data. Moreover, the compatibility of VNA with older data storage systems is another significant determinant of the industry.

Dynamics

The Growing Role in Enhancing Patient Care and Clinical Efficiency

Propelled by breakthroughs in imaging technology and the digitization of healthcare records, the exponential increase of medical imaging data requires robust data management systems. Healthcare providers manage significant volumes of imaging data, including X-rays, MRIs and CT scans, necessitating effective systems for storing, retrieving and exchanging this data.

Furthermore, the transition towards value-based care models, which give priority to achieving high-quality results and cost-efficiency, emphasizes the need of making decisions based on quantitative data and delivering integrated care. Virtual Network Assistant (VNA) and Picture Archiving and Communication System (PACS) technologies are crucial in facilitating healthcare providers to utilize medical imaging data for precise diagnosis, treatment planning and close monitoring of patient progress.

Through their ability to streamline data administration and analysis, these solutions make a valuable contribution to the enhancement of clinical processes, minimal diagnostic errors and improved patient outcomes. With the increasing demand for enhanced patient care and safety, along with improvements in healthcare technology, the Vendor Neutral Archive (VNA) & PACS market is projected to see substantial expansion in the foreseeable year.

Enhancing Interoperability and Managing Medical Imaging Data

The imperative for interoperability and data interchange provides a compelling impetus for VNAs. Healthcare systems frequently depend on a wide range of information technology platforms and applications, such as picture archiving and communication systems (PACS) and electronic health records (EHRs). Efficient data sharing between these systems is essential for delivering comprehensive patient care.

Virtual Network Architectures (VNAs) serve as central repositories, bridging the interoperability gap and enabling the access and utilization of patient data across different healthcare environments. The exponential increase in medical imaging data is a major catalyst for Virtual Network Assistants (VNAs), especially in radiology and imaging departments.

The widespread adoption of imaging technology, including X-rays, MRIs and CT scans, produces enormous quantities of digital picture data. Virtual Network Assistants (VNAs) provide specialized capabilities to effectively manage and preserve extensive datasets, therefore guaranteeing prompt accessibility of crucial medical images to healthcare practitioners as required

The Impact of Lack of Standardization and High Costs

The absence of uniform protocols and interoperability frameworks adds complexity to the sharing of data and collaboration among healthcare organizations, therefore impeding the smooth transfer of medical imaging and patient records. Consequently, healthcare workers have challenges with interoperability when retrieving patient data from various systems or moving images between institutions, resulting in delays in clinical processes and possibly jeopardizing patient care.

Moreover, the high installation and maintenance expenses linked to establishing VNA and PACS systems, including expenditures in infrastructure, software and training, limit the acceptance, especially in healthcare settings with limited resources. Hence, the continuous costs associated with system maintenance, updates and cybersecurity enhancements exacerbate the financial burden on healthcare organizations.

Segment Analysis

The global vendor neutral archive (VNA) and PACS market is segmented based on imaging modality, type, mode of delivery, usage model and region.

The Conventional Approach And Ease Of Operation In The On-Site (Premise) Setup

The on-site implementation strategy is the conventional approach to software development. Healthcare enterprises and hospitals predominantly favor on-premises data storage for the purpose of storing and managing patient data. When customers require migration to new technology or modification of their legacy systems, they choose the on-site form of delivery.

Given the novelty of VNA and PACS technologies, certain end-users or service providers have a preference for the on-site method of delivery. Therefore, the large revenue share in the analyzed market is anticipated to be attributed to on-premises software, due to its growing use by service providers worldwide. The on-premises delivery methodology enables customized integration with pre-existing corporate systems, so offering enhanced security due to the actual placement of servers and data within service providers situated within the workplace.

In May 2022, Cleo Integration, a cloud-based integration platform, reported that on-premises software was implemented and managed internally at a physical office rather than being hosted on a cloud infrastructure provided by a vendor. These operate under the oversight of the company, while the systems and data are still under the sole control of the company. Therefore, the security linked to the method of delivery is anticipated to stimulate the expansion of the segment in the analyzed market.

Geographical Penetration

North America Is Driven By Rising Need For The Standardization Of Medical Picture Archiving And More

Anticipated expansion in the Vendor-Neutral Archive (VNA) and PACS market in North America is driven by rising need for the standardization of medical picture archiving, cost reduction in data storage and the interoperability of VNA with legacy data archive systems. Furthermore, the robust healthcare IT infrastructure, the existence of prominent industry participants and the strategic actions implemented by market players in countries like US are enhancing the expansion of the market.

Through the introduction of novel products, prominent manufacturers are actively contributing to the expansion of the market in the region. By way of example, RamSoft introduced Omega AI VNA in August 2021. The archive is vendor-neutral and facilitates frictionless interchange of images and imaging data among healthcare organizations. Omega AI VNA integrates images and data from several systems to provide clinicians with a comprehensive overview of a patient's medical historical records.

In recent year, GE Healthcare introduced Edison True PACS, a cloud-based Picture Archive and Communication System (PACS) classified as next-generation. Presently, it is a diagnostic imaging and workflow solution that is accessible in US. The aforementioned launches are driving the expansion of the market.

Competitive Landscape

The major global players in the market include Agfa-Gevaert Group, Dell Technologies Inc., FUJIFILM Holdings Corporation, GE Healthcare, IBM Corporation, Koninklijke Philips NV, Lexmark International Inc., McKesson Corporation, Novarad Corporation and Siemens Healthineers AG.

Russia-Ukraine War Impact Analysis

The war between Russia and Ukraine has disrupted the healthcare technology industry, particularly affecting Vendor Neutral Archive (VNA) and Picture Archiving and Communication Systems (PACS). The ongoing violence has exerted pressure on supply chains, resulting in inadequate availability of essential hardware and software components. Consequently, the prompt implementation and upkeep of these systems have been hindered.

The subsequent delays and escalated expenses can impede the capacity of healthcare facilities to deploy and enhance VNA and PACS solutions, therefore impacting their ability to effectively handle and exchange medical pictures. Furthermore, the geopolitical volatility has intensified cybersecurity vulnerabilities, resulting in heightened dangers to the security and privacy of data.

Healthcare professionals are required to negotiate a setting characterized by increased susceptibility, which adds complexity to the administration of VNA and PACS systems and gives rise to challenges regarding data security. The present scenario intensifies the economic strain on healthcare organizations, who are already under pressure because to the ongoing conflict and affects their capacity to guarantee uninterrupted availability of patient information and medical imaging. .

By Imaging Modality

  • Angiography
  • Mammography
  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Other Imaging Modalities

By Type

  • PACS
  • VNA Software

By Mode of Delivery

  • On-Site (Premise)
  • Hybrid
  • Cloud-hosted

By Usage Model

  • Single Department
  • Multiple Departments
  • Multiple Sites

By Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In January 2024, RAMSoft (Canada) introduced the imaging EMR solution, OmegaAI. The solution is a cloud-native, serverless imaging EMR software platform that consolidates VNA, Enterprise Imaging, PACS, RIS, simplified image exchange/sharing, routing & storage, a zero-footprint (ZFP) viewer, unified worklist, radiology reporting, document management, peer, patient portal and a real-time business intelligence and analytics solution.
  • In November 2023, InsiteOne (US) declared its intention to purchase BRIT Systems' cloud native RIS/PACS/VNA solution to enhance imaging efficiency. The merger will persist in prioritizing the development of cost-efficient solutions that enhance operational efficiency and elevate the quality of patient care.
  • In February 2023, the medical imaging firm Avicenna was established. AI introduced CINA-iPE, an AI solution certified by CE, which employs image analysis of chest CT scans to detect accidental pulmonary embolism. CINA-iPE is the inaugural application inside CINA Incidental, a recently developed collection of medical imaging solutions developed by Avicenna. Artificial intelligence is capable of identifying unknown abnormalities on CT scans.
  • In April 2022, US Department of Defense (DoD) contracted with FUJIFILM Holdings Corporation to develop the Synapse PACS solution. This solution aimed to standardize the digital imaging networks' picture archiving and communication systems (DIN-PACS) of US Naval and Air Force medical treatment facilities for a period of 10 years.

Why Purchase the Report?

  • To visualize the global vendor neutral archive (VNA) and PACS market segmentation based on imaging modality, type, mode of delivery, usage model and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the vendor neutral archive (VNA) and PACS market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global vendor neutral archive (VNA) and PACS market report would provide approximately 70 tables, 64 figures and 212 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: ICT207

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Imaging Modality
  • 3.2. Snippet by Type
  • 3.3. Snippet by Mode of Delivery
  • 3.4. Snippet by Usage Model
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Growing Role in Enhancing Patient Care and Clinical Efficiency
      • 4.1.1.2. Enhancing Interoperability and Managing Medical Imaging Data
    • 4.1.2. Restraints
      • 4.1.2.1. The Impact of Lack of Standardization and High Costs
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Imaging Modality

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 7.1.2. Market Attractiveness Index, By Imaging Modality
  • 7.2. Angiography*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Mammography
  • 7.4. Computed Tomography
  • 7.5. Magnetic Resonance Imaging
  • 7.6. Ultrasound
  • 7.7. Other Imaging Modalities

8. By Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.1.2. Market Attractiveness Index, By PolymTypeer
  • 8.2. PACS*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. VNA Software

9. By Mode of Delivery

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 9.1.2. Market Attractiveness Index, By Mode of Delivery
  • 9.2. On-Site (Premise)*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Hybrid
  • 9.4. Cloud-hosted

10. By Usage Model

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage Model
    • 10.1.2. Market Attractiveness Index, By Usage Model
  • 10.2. Single Department*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Multiple Departments
  • 10.4. Multiple Sites

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage Model
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. US
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage Model
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage Model
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage Model
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage Model

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Agfa-Gevaert Group*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Dell Technologies Inc.
  • 13.3. FUJIFILM Holdings Corporation
  • 13.4. GE Healthcare
  • 13.5. IBM Corporation
  • 13.6. Koninklijke Philips NV
  • 13.7. Lexmark International Inc.
  • 13.8. McKesson Corporation
  • 13.9. Novarad Corporation
  • 13.10. Siemens Healthineers AG

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!